<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb Company </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> Dec-31-1996 <PERIOD-END> Jun-30-1996<F1> <CASH> 1,124 <SECURITIES> 491 <RECEIVABLES> 2,468<F2> <ALLOWANCES> 0 <INVENTORY> 1,555 <CURRENT-ASSETS> 6,729 <PP&E> 6,422 <DEPRECIATION> 2,624 <TOTAL-ASSETS> 13,750 <CURRENT-LIABILITIES> 4,766 <BONDS> 572 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 6,011 <TOTAL-LIABILITY-AND-EQUITY> 13,750 <SALES> 7,365 <TOTAL-REVENUES> 7,365 <CGS> 1,896 <TOTAL-COSTS> 1,896 <OTHER-EXPENSES> 1,525 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 38 <INCOME-PRETAX> 1,945 <INCOME-TAX> 564 <INCOME-CONTINUING> 1,381 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,381 <EPS-PRIMARY> 2.75 <EPS-DILUTED> 0 <FN> <F1>Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2>Receivables are reported net of allowances for doubtful accounts.